GSK's business development team have been working overtime of late, with three R&D deals announced in the last few days across Alzheimer's disease and cancer. The Alzheimer's agreement – with ...

APOE is the strongest risk gene for late onset Alzheimer’s disease and its expression is upregulated in microglia in response to amyloid beta. Here, the authors show that the APOE isoforms show ...

Correspondence to Dr Adnan H Siddiqui, Department of Neurosurgery and Radiology and Canon Stroke and Vascular Research Center, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, ...

Rothermel and colleagues present three endoscopically implemented 3D-printed magnetically actuatable micro-optical systems. Active features such as zoom, fiber bundle resolution enhancement and ...